companydata.dkcompanydata.dk

PHARMACEUTICAL ECONSULTING A/S: Financial statements 2013

CVR: 30815378

Source: annual report 2013, Danish Business Authority

01/10/2012 – 30/09/2013

PHARMACEUTICAL ECONSULTING A/S (CVR 30815378) has filed annual accounts for 2013. In 2013, the company reported a net result of DKK 0 compared with DKK 397,364 the year before. Equity in the 2013 report amounted to DKK 0.

Equity
DKK 0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2013--00-
2012--1.8 mio.397 t.-1.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2013

PHARMACEUTICAL ECONSULTING A/S: The 2012 annual report is outMar 31, 2013

PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2012. Gross profit came to DKK -1,783,587, and the net result was DKK 397,364.

About PHARMACEUTICAL ECONSULTING A/S

PHARMACEUTICAL ECONSULTING A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2007. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Steen Otto Rugaard. The board consists of Pernille Laurberg Rugaard (chair), Hanne Laurberg Olesen and Steen Otto Rugaard. The company is owned by RUGAARD HOLDING ApS. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 6,113,709 and a net result of DKK -1,066,960 compared with DKK -643,853 the year before. Equity in the 2025 report amounted to DKK 5,152,605.

Source: annual report 2025, Danish Business Authority